TFF PHARMACEUTICALS, INC. Proceeds from Common Stock Issued
TFF PHARMACEUTICALS, INC. reported Proceeds from Common Stock Issued of $526.87 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2024-09-30 was $220.78K, a 783.12% increase year-over-year.
- TFF PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2024-06-30 was $293.50K.
- TFF PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2024-03-31 was $12.58K.
- TFF PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $34.99K.
- TFF PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2023 was $60.27K, a 85.10% decline from fiscal 2022.
- TFF PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2022 was $404.56K, a 124.49% increase from fiscal 2021.
- TFF PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2021 was $180.21K.
- TFF PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2019 was $21.85M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2024-09-30 | $220.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $514.28K derived: sum of 2 quarters · filed 2024-11-20 | $526.87K 10-Q · filed 2024-11-20 | $561.86K derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-06-30 | $293.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $306.09K 10-Q · filed 2024-08-14 | $341.08K derived: sum of 3 quarters · filed 2024-08-14 | $366.08K derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | $12.58K 10-Q · filed 2024-05-14 | $47.58K derived: sum of 2 quarters · filed 2024-05-14 | $72.58K derived: sum of 3 quarters · filed 2024-05-14 | |
| 2023-12-31 | $34.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $59.99K derived: sum of 2 quarters · filed 2024-03-28 | $60.27K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $25.00K 10-Q · filed 2023-11-14 | $25.27K 10-Q · filed 2024-11-20 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $404.56K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $404.56K 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.00 derived: sum of 2 quarters · filed 2023-03-31 | $1.00 derived: sum of 3 quarters · filed 2023-03-31 | $180.21K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $180.21K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $180.21K 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $180.21K 10-Q · filed 2021-05-13 | |||
| 2020-09-30 | $24.28M 10-Q · filed 2020-11-05 | |||
| 2019-12-31 | $21.85M 10-K · filed 2021-03-10 |